Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Myriad Genetics ($MYGN) is fighting back hard against rival Quest Diagnostics' ($DGX) decision to launch a new, cheaper BRCA test that challenges its own offerings ...

With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the customer experience for health systems, hospitals, independent providers and ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...